Recombinant Human CRYGS Protein，His

CRYGS, or crystal structure of guanosine triphosphate synthase, is a crucial enzyme involved in the synthesis of guanine nucleotides, which are essential for various biochemical processes, including DNA and RNA synthesis, cell signaling, and energy metabolism. As a member of the ATP/GTP-binding protein family, CRYGS plays a vital role in cellular functions. The study of CRYGS recombinant proteins has garnered significant attention in recent years due to its potential applications in biotechnology and medicine. Understanding the structure and function of CRYGS can provide insights into its regulatory mechanisms and interactions with various ligands. Moreover, studying the recombinant protein can facilitate the development of targeted therapies for diseases linked with nucleotide metabolism disorders, including certain cancers and neurodegenerative conditions. Research efforts have focused on the expression, purification, and characterization of CRYGS recombinant proteins, utilizing advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy. These studies not only enhance our comprehension of CRYGS's enzymatic activity but also pave the way for drug design and the discovery of novel inhibitors. Consequently, the investigation of CRYGS recombinant proteins is pivotal in unlocking new therapeutic strategies and understanding fundamental biological processes.